The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.
Călin Nicolescu
Health
Foto Pixabay
Always see our news on Google
People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
Latest News
22:55
Cristian Bușoi, Secretary of State at the Ministry of Energy, assures that Romanians will not receive double electricity bills for the same consumption next winter
22:48
Police conducted searches in a case involving card fraud after foreign tourists were allegedly deceived in the Old Town.
22:22
Radu Miruță announces measures for Romanian grain exports and denies that Ukrainian trains are being prioritized at the Port of Constanța
22:14
Marco Rubio urges Europe to “wake up from sleep” and strengthen its defense
21:54
Bulgaria invites Romania and Turkey for consultations after drone attacks on commercial vessels in the Black Sea
See more news
NEWS ON THE SAME TOPICS
International
Germany will provide €400 million to maintain Sanofi’s insulin production and reduce the risk of shortages in Europe
IT&C knowledge
Novo collaborates with Anthropic to use artificial intelligence in the research and development of new medicines
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
